BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

643 related articles for article (PubMed ID: 17323842)

  • 1. Nitric oxide-dependent endothelial function and cardiovascular disease.
    Desjardins F; Balligand JL
    Acta Clin Belg; 2006; 61(6):326-34. PubMed ID: 17323842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide and the cardiovascular system: cell activation, vascular reactivity and genetic variant.
    Dias RG; Negrão CE; Krieger MH
    Arq Bras Cardiol; 2011 Jan; 96(1):68-75. PubMed ID: 21308339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial dysfunction: a global response].
    López-Farré A; Farré J; Sánchez de Miguel L; Romero J; González-Fernández F; Casado S
    Rev Esp Cardiol; 1998; 51 Suppl 6():18-22. PubMed ID: 10050140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrin-linked kinase regulates vasomotor function by preventing endothelial nitric oxide synthase uncoupling: role in atherosclerosis.
    Herranz B; Marquez S; Guijarro B; Aracil E; Aicart-Ramos C; Rodriguez-Crespo I; Serrano I; Rodríguez-Puyol M; Zaragoza C; Saura M
    Circ Res; 2012 Feb; 110(3):439-49. PubMed ID: 22194624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular nitric oxide: Beyond eNOS.
    Zhao Y; Vanhoutte PM; Leung SW
    J Pharmacol Sci; 2015 Oct; 129(2):83-94. PubMed ID: 26499181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting NOS as a therapeutic approach for heart failure.
    Tang L; Wang H; Ziolo MT
    Pharmacol Ther; 2014 Jun; 142(3):306-15. PubMed ID: 24380841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obesity, atherosclerosis and the vascular endothelium: mechanisms of reduced nitric oxide bioavailability in obese humans.
    Williams IL; Wheatcroft SB; Shah AM; Kearney MT
    Int J Obes Relat Metab Disord; 2002 Jun; 26(6):754-64. PubMed ID: 12037644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory role of nitric oxide in cardiac performance.
    Smiljić S; Nestorović V; Savić S
    Med Pregl; 2014; 67(9-10):345-52. PubMed ID: 25546983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial dysfunction, endothelial nitric oxide bioavailability, tetrahydrobiopterin, and 5-methyltetrahydrofolate in cardiovascular disease. Where are we with therapy?
    Yuyun MF; Ng LL; Ng GA
    Microvasc Res; 2018 Sep; 119():7-12. PubMed ID: 29596860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide in diabetes mellitus: too much or not enough?
    Farkas K; Sármán B; Jermendy G; Somogyi A
    Diabetes Nutr Metab; 2000 Oct; 13(5):287-97. PubMed ID: 11105972
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of nitric oxide in cardiovascular diseases.
    Naseem KM
    Mol Aspects Med; 2005; 26(1-2):33-65. PubMed ID: 15722114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide in the pathogenesis of vascular disease.
    Li H; Förstermann U
    J Pathol; 2000 Feb; 190(3):244-54. PubMed ID: 10685059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and the endothelium: history and impact on cardiovascular disease.
    Yetik-Anacak G; Catravas JD
    Vascul Pharmacol; 2006 Nov; 45(5):268-76. PubMed ID: 17052961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse models of nitric oxide synthase deficiency.
    Huang PL
    J Am Soc Nephrol; 2000 Nov; 11 Suppl 16():S120-3. PubMed ID: 11065342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary endothelial dysfunction: atherosclerosis.
    Shimokawa H
    J Mol Cell Cardiol; 1999 Jan; 31(1):23-37. PubMed ID: 10072713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tetrahydrobiopterin and endothelial function.
    Cosentino F; Lüscher TF
    Eur Heart J; 1998 Jul; 19 Suppl G():G3-8. PubMed ID: 9717048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of nitric oxide synthase isoforms for ophthalmic artery reactivity in mice.
    Laspas P; Goloborodko E; Sniatecki JJ; Kordasz ML; Manicam C; Wojnowski L; Li H; Patzak A; Pfeiffer N; Gericke A
    Exp Eye Res; 2014 Oct; 127():1-8. PubMed ID: 25017185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular regulation of endothelial nitric oxide synthase.
    Govers R; Rabelink TJ
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F193-206. PubMed ID: 11208594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.